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Paradigm change to cost-effective predictive and
preventive medicine
A paradigm change from delayed interventional approaches
to cost-effective predictive and preventive medicine pre-
sents an innovative concept for advanced healthcare. Early
detection of individual predispositions in healthy popula-
tions followed by preventive treatments tailored to the per-
son should be committed to the obligations of primary
healthcare.
Vasospastic Syndrome: definition and symptoms
Vascular deregulation (VD) or Vasospastic Syndrome is
defined as an inappropriate constriction or insufficient
dilatation in the microcirculation. Primary VD is highly
prevalent in subpopulations of young people and can
potentially predispose healthy individuals to severe disor-
ders (neurodegeneration and cancer) being, therefore, par-
ticularly attractive for predictive diagnostics and primary
prevention in targeted sub-populations [1], namely
- it occurs more frequently in females and is mani-
fested at puberty, moderating with age
- this phenomenon is even more frequent in the Japanese
population compared to Caucasians
- usually, academics are more affected by VD
- in addition to clinical signs there is an inborn increased
sensitivity to any kind of stress provocation (mechanical,
cold, emotion, etc.), altered drug sensitivity, frequently
cold extremities, altered sleep behaviour, reduced feeling
of thirst but increased smell perception, low blood-
pressure, reduced body-mass-index, more frequent
migraine compared to general population
- Compared to the general population, vasospastic
individuals tend to have a meticulous personality and
successful professional career, Figure 1.
Patient-profiling to diagnose individual
predisposition before pathology manifestation
Clinical observations, sub-cellular imaging and “gene
hunting”-investigations provide evidence for vasospasm
as a predisposition to glaucoma [3], the second leading
cause of blindness in human beings worldwide. Irrespec-
tive of glaucoma predisposition, a development of further
vasospasm-related pathologies in individuals with
(untreated) vasospastic syndrome cannot be excluded.
Patient-profiling and predictive blood-tests detecting
pathology-specific biomarker-patterns can specify indivi-
dual predisposition for effective prevention at low cost.
Patient-profiling for positive and negative
prediction of pathology development
Whereas positive prediction for patients at high risk is
important to recognize the pathology before it manifests
and at early stages, the negative prediction for individuals
at low risk help to avoid undesirable treatments and inva-
sive approaches in the case of non-predisposed indivi-
duals. Individual patient profiles are utilised for patient
modeling and risk assessment. Blood tests utilizing
“omics”-technologies are useful for creating accurate
non-invasive positive/negative predictive approaches
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Conclusions and expert recommendations
- The expression similarities between glaucoma and VD
versus controls indicate, on one hand, a predisposition
of VD individuals to glaucomatous damage, and, on the
other hand, an important role of a vascular component
in glaucoma pathology.
- Expression dissimilarities between VD and glau-
coma patients might indicate some glaucoma-specific
Figure 1 Symptoms and typical attitude of individuals with Vasospastic Syndrome: individuals with primary vasospastic deregulation tend to a
meticulous personality and successful professional career such as the young female on the left image [2]
Figure 2 Proteomics-imaging of blood-biomarkers (ex vivo identification in circulating leukocytes) specific for normal-tension glaucoma (NTG). A.
Top: The pathology-specific protein-cluster is completely suppressed in both NTG and vasospasm in contrast to controls. B. Bottom: The
marked protein SSP2602 is highly up-regulated in both NTG and vasospasm; this protein normally is not expressed by circulating leukocytes of
controls – healthy individuals without vasospasm [4]
Golubnitschaja et al. EPMA Journal 2014, 5(Suppl 1):A155
http://www.epmajournal.com/content/5/S1/A155
Page 2 of 3
pathomechanisms that are not involved in the stage of
predisposition by VD.
- Both expression similarities and dissimilarities could
be useful in ascertaining the diagnosis of glaucoma,
positive and negative prediction.
- Molecular rearrangement in leukocytes of both VD
and glaucoma patients has been shown to be typical for
circulating leukocytes during vascular injury and
includes an up-regulated adhesive protein expression via
ICAM1, an induced chemo-taxis via P2Y purinoceptors,
a mobilisation of intracellular Ca2+ response via Na
+/Ca2+ exchanger, and the core of tissue remodelling
metalloproteinases.
- Pathology-specific molecular and sub-cellular pat-
terns may create the basis for the development of more
specific and non-invasive molecular imaging technolo-
gies in early/predictive glaucoma diagnostics.
- Development of some other “down-stream” patholo-
gies different from glaucoma but related to primary vasos-
pastic syndrome cannot be excluded and should be
investigated through well designed large-scaled studies.
- Predictive molecular-profiling in blood can specify
individual predisposition for effective prevention to low
costs [5].
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